Swiss Group For Clinical Cancer Research

Bern (Switzerland ch)
Oncology
Clinical endpoint Breast Cancer Progression-free survival Durvalumab Neoadjuvant Therapy Regimen Carboplatin Denosumab PET Imaging Non-Small Cell Lung Cancer
Watch Introduction

Bibliometric indicators

Evolution over the last years of activity

Showing the period - Sept. 2024

1,109
Activity
3%

Total documents

2.86
Impact
3%

Normalized Impact

299
Excellence
3%

Highly Cited Papers (Top 10%)

57.5
Leadership
3%

Leadership (%)

55.4
Mobility & Collaboration
3%

International Collaboration (%)

68
Excellence
3%

Outstanding papers (Top 1%)

15.3
Leadership
3%

Women Leading (%)

8.6
Leadership
3%

Women Leading International (%)

55.3
Open Access
3%

Open Access (%)

Main Research Fields (top 9 by publications)

Indicators:

Net Change
3%

Net Change
3%

Net Change
3%

Net Change
3%

Net Change
3%

Net Change
3%

Net Change
3%

Net Change
3%

Net Change
3%

Human Resources

Historical perspective

From to Sept. 2024

Current resources

Quick filters

Career Stage
Occasional Junior Researcher Senior Leading
Performance
Standard Good Excellent Outstanding
Gender
Male Female
Reset
0

Personnel

0.0

Papers / Personnel

0

Leading women (%)

0
0

Gender (%)

0

Papers / Permanent researchers

0

Papers / Leading researchers

Career stage

Performance

Years of Activity

ONE Index (distribution)

ONE Index by Main Research Fields

ONE Index vs. Years of Activity

Main authors

ID Name Gender Discipline Career Stage ONE Index Years Activity NDocs RCI HCP Leader Collab.
1 Pagani, Olivia female Oncology Leading researcher 880 32 290 3.81 59 36.9% 50.7%
2 Hayoz, Stefanie female Oncology, Pulmonary and Respiratory Medicine Senior researcher 763 18 164 1.77 33 6.1% 65.9%
3 Klingbiel, Dirk male Oncology Senior researcher 748 22 118 2.46 31 5.9% 50.9%
4 Xyrafas, Alexandros male Oncology, Pulmonary and Respiratory Medicine Senior researcher 728 16 58 2.05 13 0.0% 32.8%
5 Schneider, Martina female Molecular Biology Leading researcher 686 71 196 1.72 34 23.0% 25.5%
6 Schär, Sämi male Genetics, Ecology, Evolution, Behavior and Systematics Researcher 666 14 43 1.31 6 30.2% 60.5%
7 Qi‐yu, LI Molecular Biology Senior researcher 666 26 105 1.58 19 32.4% 14.3%
8 Bernard C. M. Sordat Immunology Leading researcher 640 60 149 1.84 31 37.6% 16.1%
9 Holer, Lisa female Oncology Junior researcher 629 4 12 1.44 3 0.0% 25.0%
10 Daniel J. Dietrich Oncology Leading researcher 598 52 96 2.91 22 12.5% 34.4%
11 Simcock, Mathew male Molecular Biology, Oncology, Hematology Senior researcher 564 22 71 1.37 13 2.8% 38.0%
12 Schär, Corinne female Pulmonary and Respiratory Medicine Researcher 540 7 11 2.35 2 0.0% 63.6%
13 Stephanie ‐ Rondeau Pathology and Forensic Medicine, Oncology, Genetics Researcher 517 12 19 1.82 4 0.0% 63.2%
14 Brauchli, Peter male Oncology Leading researcher 499 32 66 1.59 13 15.2% 28.8%
15 Eric Innocents Eboulet Pulmonary and Respiratory Medicine Researcher 493 12 23 2.83 5 4.4% 39.1%
16 Rusterholz, Corinne female Pulmonary and Respiratory Medicine, Pediatrics, Perinatology and Child Health, Oncology Senior researcher 474 31 48 2.33 10 22.9% 25.0%
17 Christina Biaggi Rudolf Pulmonary and Respiratory Medicine Researcher 471 12 23 1.05 4 0.0% 56.5%
18 Thierstein, Sandra female Pulmonary and Respiratory Medicine Senior researcher 431 22 30 1.99 4 0.0% 33.3%
19 Shu‐Fang Hsu Schmitz Oncology Senior researcher 402 32 49 1.39 8 28.6% 44.9%
20 Biaggi, Christine female Pulmonary and Respiratory Medicine Researcher 401 31 21 2.59 5 0.0% 52.4%
21 Hawle, Hanne female Oncology Senior researcher 374 36 36 1.81 8 8.3% 63.9%
22 Baertschi, Daniela female Oncology Researcher 368 14 23 0.89 2 0.0% 34.8%
23 Leoncini‐Franscini, Leda female Genetics, Pathology and Forensic Medicine Occasional author 368 26 6 2.53 2 33.3% 50.0%
24 Berardi Vilei, Simona female Oncology, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine Researcher 363 20 17 1.16 2 0.0% 41.2%
25 Kaeser, Matthias male Molecular Biology Occasional author 362 24 10 3.07 5 50.0% 30.0%
880
One Index
 Pagani, Olivia PhD   0000-0001-9739-6299 290 docs (1993 - 2024)  
Breast Cancer , Exemestane , Metastatic Breast Cancer , Letrozole , Neoadjuvant Therapy
763
One Index
 Hayoz, Stefanie PhD   0000-0002-2265-6559 164 docs (2007 - 2024)  
Clinical endpoint , Neoadjuvant Therapy , Prostate Cancer , Follicular lymphoma , Metastatic Prostate Cancer
748
One Index
 Klingbiel, Dirk PhD   0000-0002-9914-0243 118 docs (2003 - 2023)  
Clinical endpoint , Breast Cancer , Pertuzumab , Trastuzumab , Carboplatin
728
One Index
 Xyrafas, Alexandros PhD 58 docs (2009 - 2024)  
Clinical endpoint , Non-Small Cell Lung Cancer , Durvalumab , Circulating tumor cell , Breast Cancer
686
One Index
 Schneider, Martina PhD   0000-0001-6770-7471 196 docs (1954 - 2024)  
Clinical endpoint , Durvalumab , Phospholipid transfer protein , Dystroglycan , Cholesterylester transfer protein
666
One Index
 Schär, Sämi PhD   0000-0001-6108-4832 43 docs (2011 - 2024)  
Follicular lymphoma , Lycaenidae , Mantle Cell Lymphoma , Ants , Holarctic
666
One Index
 Qi‐yu, LI PhD   0009-0002-7308-1334 105 docs (1999 - 2024)  
Clinical endpoint , Pemetrexed , Data set , Progression-free survival , Breast Cancer
640
One Index
 Bernard C. M. Sordat PhD 149 docs (1965 - 2022)  
Nude mouse , Tumor Microenvironment , Spheroid , Clonogenic assay , Nicotinamide phosphoribosyltransferase
629
One Index
 Holer, Lisa 12 docs (2021 - 2024)  
Clinical endpoint , Atezolizumab , Durvalumab , Triple-negative breast cancer , Mucositis
598
One Index
 Daniel J. Dietrich PhD 96 docs (1973 - 2024)  
Clinical endpoint , Metastatic Colorectal Cancer , Breast Cancer , Surgical oncology , Metastatic Bone Disease
564
One Index
 Simcock, Mathew PhD 71 docs (2003 - 2024)  
Clinical endpoint , Pomalidomide , Refractory (planetary science) , Temozolomide , Tolerability
540
One Index
 Schär, Corinne PhD 11 docs (2018 - 2024)  
Metastatic Bone Disease , Clinical endpoint , Denosumab , Bone Metastasis , Bone pain
517
One Index
 Stephanie ‐ Rondeau PhD 19 docs (2013 - 2020)  
Follicular lymphoma , Clinical endpoint , Rituximab , Nelfinavir , Regimen
499
One Index
 Brauchli, Peter PhD 66 docs (1993 - 2024)  
Clinical endpoint , Breast Cancer , Metastatic Colorectal Cancer , Neoadjuvant Chemotherapy , Regimen
493
One Index
 Eric Innocents Eboulet PhD 23 docs (2013 - 2022)  
Durvalumab , Cancer Imaging , Clinical endpoint , Non-Small Cell Lung Cancer , Tumor Staging
474
One Index
 Rusterholz, Corinne PhD 48 docs (1994 - 2023)  
Durvalumab , Clinical endpoint , Syncytiotrophoblast , Fetal DNA Analysis , Maternal Plasma DNA Sequencing
471
One Index
 Christina Biaggi Rudolf PhD 23 docs (2013 - 2024)  
Clinical endpoint , Progression-free survival , Enzalutamide , Follicular lymphoma , Prophylactic cranial irradiation
431
One Index
 Thierstein, Sandra PhD 30 docs (2003 - 2023)  
Non-Small Cell Lung Cancer , Cancer Imaging , Tumor Staging , Radiotherapy , Stereotactic Body Radiation Therapy
402
One Index
 Shu‐Fang Hsu Schmitz PhD 49 docs (1993 - 2023)  
Follicular lymphoma , Tolerability , Rituximab , Mantle Cell Lymphoma , Clinical endpoint
401
One Index
 Biaggi, Christine PhD 21 docs (1994 - 2022)  
Clinical endpoint , Everolimus , Mantle Cell Lymphoma , Carboplatin , Pemetrexed
374
One Index
 Hawle, Hanne PhD 36 docs (1989 - 2023)  
Clinical endpoint , Breast Cancer , Follicular lymphoma , Nelfinavir , Fulvestrant
368
One Index
 Baertschi, Daniela PhD   0000-0002-1214-5173 23 docs (2011 - 2023)  
Clinical endpoint , Metastatic Colorectal Cancer , Neoadjuvant Therapy , Bevacizumab , Panitumumab
368
One Index
 Leoncini‐Franscini, Leda 6 docs (1999 - 2014)  
Therapeutic drug monitoring , Follicular lymphoma , Mantle Cell Lymphoma , Therapeutic Targets , Chronic myelogenous leukemia
363
One Index
 Berardi Vilei, Simona PhD   0000-0002-6226-9123 17 docs (2005 - 2024)  
Regimen , Periosteum , Metastatic Prostate Cancer , Rituximab , Bendamustine
362
One Index
 Kaeser, Matthias   0000-0003-0050-9408 10 docs (2001 - 2015)  
p53 , Chromatin immunoprecipitation , Wild type , Puma , Epigenetic Reprogramming